Byondis B.v.

This study is the first time the drug BYON4228 is being tested in humans. It is for people with a type of blood cancer called B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior treatments. The study will test the drug alone and combined with ano…

This early-phase trial tests a new drug called BYON4228, alone or with another drug (pembrolizumab), in people with advanced solid tumors that have not responded to standard treatments. The study aims to find a safe dose and see if the drug can shrink tumors. Only 7 participants …